Drug Monitoring, Pregabalin, Quantitative, with medMATCH, Urine

Last Modified: 6/24/2021 6:40:49 AM

  Medicare Medical Necessity Restrictions May Apply
Medical Necessity Documentation: G0480 - may need ABN
Client Notes:  Please contact 266-1500 (Option 1) to acquire the appropriate specimen type
Patient Preparation:  
Specimen Requirements: 20.0 mL Urine in a Green Clinical Drug Test Collection Cup
Collection Instructions:  
Minimum Volume: 7.0 mL Urine
Transport & Storage: Temperature/Stability: 14 days Ambient
14 days Refrigerated
30 days Frozen

Transport Ambient
Rejection Criteria: Preserved samples
Reference Range: Pregabalin <1000 ng/mL
Critical Ranges:  
Test Comments:  
Methodology: Mass Spectrometry (MS)
Clinical Significance:  Drug Monitoring, Pregabalin, Quantitative, with medMATCH, Urine - The management of patients use of controlled substances is an increasing focus of law enforcement to ensure that prescribed medications arent diverted, and is critical to the successful outcome of many pharmaco-therapies. Urine drug testing for the presence or absence of prescribed medications and illicit drugs is a strategy designed to help the treating physician monitor their patients for compliance with that physicians directive(s).
Custom Panel: No


Turn Around Time: 4 to 5 days
Days Performed: Sunday, Monday, Tuesday, Wednesday, Thursday, Friday, Saturday
Sites Performed: Quest - Chantilly
PHL Test Code: PGABM
EPIC Test Code: LAB3181
Send Out Test Code: 39410
Alternate Test Names: Lyrica; Prescription Drug Monitoring,Pain Management
Included Tests:  
CPT Coding: 80366; G0480

Go back to the top of the page.